Severe cutaneous reactions caused by barbiturates in seven Iranian children

Setareh Mamishi1, Fatemeh Fattahi, Zahra Pourpak

  • 1Department of Infectious Diseases, Immunology, Asthma and Allergy Research Institute, Children Medical Center, Medical Sciences/University of Tehran, Tehran, Iran.

Insights

Barbiturates can cause severe skin reactions like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in children. Early detection and supportive care are crucial for survival in these rare but serious adverse drug reactions.

Area of Science:

  • Pediatric Dermatology
  • Pharmacovigilance
  • Adverse Drug Reactions

Background:

  • Severe adverse cutaneous reactions, including erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), are rare but serious conditions.
  • Antiepileptic drugs, particularly carbamazepine, lamotrigine, barbiturates (phenobarbital, phenytoin), are common culprits.
  • This study focuses on seven pediatric cases of severe cutaneous reactions attributed to barbiturates.

Observation:

  • Seven children aged 2-11 years presented with symptoms 1-3 weeks after initiating barbiturate therapy.
  • Symptoms included a prodrome of malaise, fever, cough, and anorexia, followed by evolving skin lesions (rash to bullae) and mucosal involvement.
  • Barbiturate treatment was immediately discontinued, and patients received supportive care.

Findings:

  • All seven pediatric patients experienced severe cutaneous adverse reactions linked to barbiturate use.
  • The clinical presentation involved characteristic mucocutaneous lesions and a prodromal phase.
  • Prompt cessation of the offending drug and supportive management led to positive patient outcomes.

Implications:

  • Physicians must consider barbiturate-induced severe cutaneous reactions in the differential diagnosis of mucocutaneous lesions.
  • Early recognition and intervention are vital for improving survival rates in SJS/TEN.
  • The presented cases highlight the effectiveness of immediate drug withdrawal and supportive care in managing these life-threatening conditions in children.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...